Response to 'Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after patients on antiprogrammed cell death-1 inhibition with nivolumab'.
Response to 'Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after patients on antiprogrammed cell death-1 inhibition with nivolumab'. J Eur Acad Dermatol Venereol. 2018 02; 32(2):e61-e62.